Biologics News

WASHINGTON — In this video from the American Academy of Orthopaedic Surgeons Next Generation of Biologics Symposium, Shane A. Shapiro, MD, spoke about the need to standardize biologic therapies for musculoskeletal conditions.

WASHINGTON — In this video from the American Academy of Orthopaedic Surgeons Next Generation of Biologics Symposium, Charles K.F. Chan, PhD, discussed the use of skeletal and progenitor stem cells for the regeneration of bone and cartilage.

WASHINGTON — Jason L. Dragoo, MD, FAAOS, spoke about the next generation of orthobiologics at the American Association of Orthopaedic Surgeons Next Generation of Biologics Symposium, here.

WASHINGTON — At the American Academy of Orthopaedic Surgeons Next Generation of Biologics Symposium, Scott Rodeo, MD, FAAOS, spoke about a clinical study that used gene-modified human umbilical vein endothelial cells in rotator cuff repair.

Anika Therapeutics Inc. has announced additional FDA 510(k) clearance of its Tactoset injectable bone substitute, which is now indicated for use with autologous bone marrow aspirate, according to a press release.

Results published in Journal of Orthopedic Surgery showed that a thin, laser-etched osteochondral allograft yielded positive short-term clinical outcomes in isolated articular cartilage defects in the knee.

NEW ORLEANS — Results showed integrating clinical outcomes with laboratory analysis of biological samples may lead to a better understanding of the variable responses to platelet-rich plasma therapy for musculoskeletal conditions.

NEW ORLEANS — Although augmentation of rotator cuff pathology with patches and grafts may play a role in decreasing the retear rate, a presenter said more research is needed to define the best indications and graft source.

NEW ORLEANS — Use of an acellular implant made of aragonite may improve outcomes in patients with early arthritis compared with debridement or microfracture, according to results presented at the Biologic Association Annual Summit.

NEW ORLEANS — In this video, Shane A. Shapiro, MD, discusses characterizing, dosing and investigating therapeutic mechanisms of action of platelet-rich plasma.